Literature DB >> 14155842

RELATIONSHIP OF PLASMA ALDADIENE LEVELS AND ANTIMINERALOCORTICOID EFFECTS OF SPIRONOLACTONE IN THE LABORATORY.

C M KAGAWA, D J BOUSKA, M L ANDERSON.   

Abstract

Entities:  

Keywords:  ADRENALECTOMY; BLOOD; DESOXYCORTICOSTERONE; DOGS; EXPERIMENTAL LAB STUDY; NATRIURESIS; PHOTOMETRY; POTASSIUM; RATS; SPIRONOLACTONE; URINE

Mesh:

Substances:

Year:  1964        PMID: 14155842     DOI: 10.3181/00379727-115-29052

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  7 in total

Review 1.  Primary aldosteronism and salt.

Authors:  John W Funder
Journal:  Pflugers Arch       Date:  2014-12-13       Impact factor: 3.657

2.  Canrenone--the principal active metabolite of spironolactone?

Authors:  L E Ramsay; J R Shelton; D Wilkinson; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

3.  Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.

Authors:  W Sadée; U Abshagen; C Finn; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Comparison of single and divided daily dose spironolactone in the control of hypertension.

Authors:  G M Bell; L Fananapazir; J L Anderton
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

5.  Improved method for comparative evaluation of aldosterone antagonists in healthy man.

Authors:  J Casals-Stenzel; J Schmalbach; W Losert
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

6.  Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.

Authors:  D Levine; L Ramsay; R Auty; R Branch; M Tidd
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 7.  Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine.

Authors:  John W Funder
Journal:  Integr Blood Press Control       Date:  2013-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.